Natural History of COVID-19-Related Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT04830774

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04830774
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Belgium, Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04830774. Allocation not applicable; no masking; primary purpose screening. Start 2021-04-15 (actual); primary completion 2021-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Natural History of COVID-19-Related Atrial Fibrillation
Acronym
unCOVer-AF
Condition
COVID-19
Condition
Atrial Fibrillation New Onset
Intervention (Device)
ILR, PMK, ICD
Lead sponsor
Texas Cardiac Arrhythmia Research Foundation (class: other)

Record details

Record id
cardio:ct-nct04830774
Content hash
95265407ebfdbac98f1e3bedeb4975f661a9d3047f9d689fae482c9da420d5db